In Romania, Janssen has committed itself to making the country an example of how to tackle and combat hepatitis C by 2020. This ambitious plan of Janssen started in 2012 and seeks to go from 5,000 annual patient treatments per year to 60-80,000 treatments via a public-private collaboration.  


To deal with this in an efficient, innovative and sustainable way, a new integrated model is needed which covers all the relevant aspects: the efficiency of the HCV diagnosis and treatment process, the logistics, recognition of the problem among the general public in the health care field and by policy-makers.  

Hepatitis C infections occurred in the early 1990s in Romania mainly through unsafe medical and dental procedures, (illegal) abortions and unsafe blood transfusions.  Hepatitis C is very common in Romania, annual screenings are limited and only 1% of cases are treated.  The budget required to treat 10% of all cases would swallow up large part of the national health care budget.



Janssen takes responsibility for its employees, patients and the local and international community.
We therefore work on deploying talent in a sustainable way and take care of the physical and mental health of personnel and their safety and continuing training.

Patient associations receive support from Janssen so they can realize their projects independently. Janssen pays special attention to young persons (training), informs local residents and becomes involved in local projects.

Access to and the affordability of health care are a core international theme at Johnson & Johnson and Janssen, who also support specific philanthropic projects.